Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Peter M. Rabinovich"'
Autor:
Peter M. Rabinovich, Samuel G. Katz
Publikováno v:
Methods in Molecular Biology ISBN: 9781071602027
Advances in academic and clinical studies during the last several years have resulted in practical outcomes in adoptive immune therapy of cancer. Immune cells can be programmed with molecular modules that increase their therapeutic potency and specif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6537aa72fad32471096643aaf7afa8
https://europepmc.org/articles/PMC7063988/
https://europepmc.org/articles/PMC7063988/
Autor:
Samuel R. Kerr, Sherman M. Weissman, Samuel G. Katz, Bao-Hui Cheng, Michael E. Hurwitz, Marina E. Komarovskaya, Alexey Bersenev, Peter M. Rabinovich, Jialing Zhang, Diane S. Krause
Publikováno v:
Journal of Immunological Methods. 474:112668
Cell-mediated cytotoxicity is a critical function of the immune system in mounting defense against pathogens and cancers. Current methods that allow direct evaluation of cell-mediated cytotoxicity suffer from a wide-range of drawbacks. Here, we prese
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 969
mRNA has become an important alternative to DNA as a tool for cell reprogramming. To be expressed, exogenous DNA must be transmitted through the cell cytoplasm and placed into the nucleus. In contrast, exogenous mRNA simply has to be delivered into t
Autor:
Peter M. Rabinovich
Publikováno v:
Methods in Molecular Biology ISBN: 9781627032599
Synthetic Messenger RNA and Cell Metabolism Modulation
Synthetic Messenger RNA and Cell Metabolism Modulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::109a44119ce445282fcb81887b88f239
https://doi.org/10.1007/978-1-62703-260-5
https://doi.org/10.1007/978-1-62703-260-5
Publikováno v:
Methods in Molecular Biology ISBN: 9781627032599
mRNA has become an important alternative to DNA as a tool for cell reprogramming. To be expressed, exogenous DNA must be transmitted through the cell cytoplasm and placed into the nucleus. In contrast, exogenous mRNA simply has to be delivered into t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8847b7c28be5d274c4e20f7d56d1fde6
https://doi.org/10.1007/978-1-62703-260-5_1
https://doi.org/10.1007/978-1-62703-260-5_1
Autor:
Peter M. Rabinovich, Stephen H. Wrzesinski, Marina E. Komarovskaya, Alexander Karpikov, Jonathan Alderman, Nai-Kong Cheung, Erkut Bahceci, Hongfen Guo, Sherman M. Weissman, Tulin Budak-Alpdogan, Richard A. Flavell
Publikováno v:
Human gene therapy. 20(1)
mRNA transfection is a useful approach for temporal cell reprogramming with minimal risk of transgene-mediated mutagenesis. We applied this to redirect lymphocyte cytotoxicity toward malignant cells. Using the chimeric immune receptor (CIR) construct
Autor:
Chihaya Imai, Erkut Bahceci, Sherman M. Weissman, Marina E. Komarovskaya, Peter M. Rabinovich, Dario Campana, Zhi-jia Ye
Publikováno v:
Human gene therapy. 17(10)
Transfection of human cells with DNA in biomedical applications carries the risk of insertional mutagenesis. Transfection with mRNA avoids this problem; however, in vitro production of mRNA, based on preliminary DNA template cloning in special vector
Autor:
Francine M. Foss, Peter M. Rabinovich, Andreas Hombach, Pavel Karkanitsa, Sherman M. Weissman, Hinrich Abken, Marina E. Komarovskaya
Publikováno v:
Cancer Research. 70:1936-1936
CD30 is a transmembrane receptor which is overexpressed on Hodgkin lymphoma and large cell anaplastic lymphoma and represents an attractive target for therapy. Current methods of immunotherapy of CD30+ lymphomas include antibody based therapy (immuno
Autor:
Tulin Budak-Alpdogan, Sherman M. Weissman, Dario Campana, Peter M. Rabinovich, Marina E. Komarovskaya, Erkut Bahceci
Publikováno v:
Blood. 110:2750-2750
Current treatment approaches for B-cell malignancies such as non-Hodgkin’s lymphoma and chronic lymphocytic leukemia are initially effective, but most patients ultimately relapse. Thus, there is a compelling need to develop novel therapies. One pro
Autor:
Peter M. Rabinovich, Marina E. Komarovskaya, Stephen H. Wrzesinski, Jonathan L. Alderman, Tulin Budak-Alpdogan, Alexander Karpikov, Hongfen Guo, Richard A. Flavell, Nai-Kong Cheung, Sherman M. Weissman, Erkut Bahceci
Publikováno v:
Human Gene Therapy; Jan2009, Vol. 20 Issue 1, p51-61, 11p